首页> Clinical cancer research : an official journal of the American Association for Cancer Research> First-Line MET Tyrosine Kinase Inhibitors versus Immunotherapy ± Chemotherapy for Patients with MET Exon 14 Skipping Mutant Metastatic NSCLC.

First-Line MET Tyrosine Kinase Inhibitors versus Immunotherapy ± Chemotherapy for Patients with MET Exon 14 Skipping Mutant Metastatic NSCLC.

导出 OA

翻译打印收藏纠错

第一作者： Federica,Pecci

第一单位： Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.;Department of Medicine and Surgery, University of Parma, Parma, Italy.

作者： Federica,Pecci ^[1] ; Hui,Li ^[2] ; Alessandro,Di Federico ^[3] ; Jia,Wu ^[2] ; Hong,Chen ^[4] ; Eleonora,Gariazzo ^[5] ; Francesco,Mantuano ^[3] ; Edoardo,Garbo ^[5] ; Mihaela,Aldea ^[5] ; Valentina,Santo ^[5] ; Don,Gibbons ^[4] ; Hai,Tran ^[4] ; Francesco,Paoloni ^[5] ; Guilherme,Rossato De Almeida ^[5] ; Giulio,Metro ^[6] ; Andrea,De Giglio ^[3] ; Francesco,Gelsomino ^[3] ; Xinan,Wang ^[7] ; Marcello,Tiseo ^[8] ; Julia,Rotow ^[5] ; Andrea,Ardizzoni ^[3] ; J Jack,Lee ^[9] ; Mark M,Awad ^[5] ; Alfredo,Addeo ^[10] ; Lingzhi,Hong ^[4] ; Marcelo V,Negrao ^[4] ; Pasi A,Jänne ^[5] ; John V,Heymach ^[4] ; Jianjun,Zhang ^[11] ; Biagio,Ricciuti ^[5] ; Xiuning,Le ^[4]

作者单位： Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.;Department of Medicine and Surgery, University of Parma, Parma, Italy. ^[1] Department of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.;Department of Imaging Physics, The University of Texas MD Anderson Cancer Center, Houston, Texas. ^[2] Medical Oncology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.;Department of Medical and Surgical Sciences (DIMEC), University of Bologna, Bologna, Italy. ^[3] Department of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. ^[4] Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts. ^[5] Medical Oncology, Department of Medicine and Surgery, University of Perugia, Perugia, Italy. ^[6] Department of Biostatistics, Harvard TH Chan School of Public Health, Boston, Massachusetts. ^[7] Department of Medicine and Surgery, University of Parma, Parma, Italy.;Medical Oncology Unit, University Hospital of Parma, Parma, Italy. ^[8] Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas. ^[9] Geneva University Hospital, Geneva, Switzerland. ^[10] Department of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.;Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas. ^[11]